Skip to main content

Prevalence of Skin Cancer Varies for Sexual Minority, Heterosexual Adults

Medically reviewed by Carmen Pope, BPharm. Last updated on July 21, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, July 19, 2024 -- With respect to their lifetime prevalence of skin cancer, sexual minority (SM) adults differ across racial and ethnic groups and among males and females, according to a study published online July 17 in JAMA Dermatology.

Katelyn J. Rypka, from the University of Minnesota in Minneapolis, and colleagues examined differences in the lifetime prevalence of skin cancer among U.S. adult females and males by sexual orientation in a cross-sectional study using data from the Behavioral Risk Factor Surveillance System from Jan. 1, 2014, to Dec. 31, 2021. Of the 1,512,400 participants studied, 53.2, 2.6, 42.2 and 2.0 percent were heterosexual females, SM females, heterosexual males, and SM males, respectively.

The researchers found that the lifetime prevalence of skin cancer was higher for SM males versus heterosexual males overall (7.4 versus 6.8 percent; adjusted odds ratio [aOR], 1.16), especially among Hispanic males (4.0 versus 1.6 percent; aOR, 3.81) and non-Hispanic Black males (1.0 versus 0.5 percent; aOR, 2.18). Compared with heterosexual females, lifetime prevalence rates were lower among SM females for non-Hispanic Whites (7.8 versus 8.5 percent; aOR, 0.86), while rates were higher among Hispanic SM females (2.1 versus 1.8 percent; aOR, 2.46) and non-Hispanic Black SM females (1.8 versus 0.5 percent; aOR, 2.33).

"Future research and public health interventions should consider race and ethnicity and individual sexual identity when addressing skin cancer and related risk behaviors, with a particular emphasis on Black and Hispanic SM females and males and White gay males," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted July 2024

Read this next

2020 to 2023 Saw Increase in Buprenorphine Dispensing for Teens

THURSDAY, Dec. 26, 2024 -- Buprenorphine dispensing increased among adolescents and decreased among young adults between 2020 and 2023, according to a research letter published...

Prevalence of Post-COVID-19 Condition in Adults 8.4 Percent in 2023

THURSDAY, Dec. 26, 2024 -- The prevalence of post-COVID-19 condition (PCC) was 8.4 percent among U.S. adults in 2023, according to a research letter published online Dec. 13 in...

COVID-19 Infection Not Linked to Changes in MS Symptom Severity

THURSDAY, Dec. 26, 2024 -- COVID-19 infection is not associated with immediate changes in multiple sclerosis (MS) symptom severity or disability, according to a study published...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.